2025年4月30日，东方生物(688298.SH)发布2025年第一季报。截至2025年4月30日，共有9个机构投资者 披露持有东方生物A股股份，合计持股量达1.11亿股，占东方生物总股本的55.04%。其中，机构投资者 包括安吉福浪莱进出口贸易有限公司、Fangs Holdings Limited Liability Company、安吉涌威创业投资合 伙企业(有限合伙)、中国工商银行股份有限公司-融通健康产业灵活配置混合型证券投资基金、招商银行 股份有限公司-广发价值核心混合型证券投资基金、香港中央结算有限公司、招商银行股份有限公司-南 方中证1000交易型开放式指数证券投资基金、汇添富基金管理股份有限公司-社保基金四二三组合、招 商银行股份有限公司-南方科创板3年定期开放混合型证券投资基金，机构投资者合计持股比例达 55.04%。相较于上一季度，机构持股比例合计下跌了0.60个百分点。 公募基金方面本期较上一季度持股减少的公募基金共计2个，包括融通健康产业灵活配置混合A/B、南 方中证1000ETF，持股减少占比达0.28%。本期较上一季未再披露的公募基金共计55个，主要包括融通 医疗保健行业混合A/ ...

Group 1 - The core viewpoint of the news is that as of April 30, 2025, institutional investors hold a significant portion of the shares of Founder Securities, with a total of 53.44 billion shares, representing 64.91% of the company's total equity [1] - The top ten institutional investors collectively hold 64.83% of the shares, with a slight decrease of 0.32 percentage points compared to the previous quarter [1] - The major institutional investors include New Founder Holdings, National Social Security Fund, China Cinda Asset Management, and several major banks and investment funds [1] Group 2 - In the public fund sector, two funds increased their holdings, accounting for a 0.15% increase, while three funds saw a slight decrease in their holdings [2] - A total of 220 public funds did not disclose their holdings in this period, including several major ETFs related to the securities industry [2]

Group 1 - Top Group (601689.SH) reported its Q1 2025 results, with 191 institutional investors holding a total of 1.223 billion shares, representing 70.35% of the total share capital [1] - The top ten institutional investors collectively hold 66.54% of the shares, with a decrease of 1.68 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 48 funds increased their holdings, accounting for 0.64% of the total, while 63 funds decreased their holdings, representing a decrease of 0.56% [2] - A total of 64 new public funds disclosed their holdings, while 623 funds did not disclose their holdings in the current period [2] Group 3 - One new social security fund disclosed its holdings in Top Group, specifically the National Social Security Fund 104 Portfolio [3] - One insurance fund decreased its holdings, while one new insurance investor disclosed its holdings in the current period [3]

Group 1 - Rongsheng Petrochemical (002493.SZ) reported its Q1 2025 results on April 30, 2025, with 18 institutional investors disclosing holdings of A-shares totaling 6.793 billion shares, representing 67.08% of the total share capital [1] - The top ten institutional investors include Zhejiang Rongsheng Holding Group Co., Aramco Overseas Company B.V., and others, with their combined holding ratio at 67.07%, a decrease of 0.75 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings compared to the previous period, while six funds reduced their holdings, indicating a slight decline in the proportion of reduced holdings [2] - One new public fund was disclosed during this period, namely Guofu CSI 300 Index Enhanced A, while 292 public funds were not disclosed again, including several major ETFs [2] - Regarding foreign investment, one foreign fund, Hong Kong Central Clearing Limited, increased its holdings slightly compared to the previous period [2]

Group 1 - The core viewpoint of the news is that the institutional ownership of Laobaixing (603883.SH) has increased, with 17 institutional investors holding a total of 423 million shares, representing 55.65% of the total share capital as of April 30, 2025 [1] - The top ten institutional investors collectively hold 55.05% of the shares, with an increase of 1.19 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds increased their holdings, accounting for a 1.28% increase, while one fund saw a slight decrease in holdings [2] - Eight new public funds were disclosed during this period, including several focused on healthcare and medical sectors [2] - One insurance fund decreased its holdings slightly, while one pension fund was no longer disclosed [2]

Core Insights - Oriental Venture (600278.SH) reported a decline in both revenue and net profit for Q1 2025, with total revenue at 8.444 billion yuan, down 3.44% year-on-year, and net profit at 55.6287 million yuan, down 7.75% year-on-year [1][3] Financial Performance - Total revenue for Q1 2025 was 8.444 billion yuan, ranking 7th among peers, a decrease of 301 million yuan from the same period last year [1] - Net profit attributable to shareholders was 55.6287 million yuan, ranking 5th among peers, a decrease of 4.6752 million yuan year-on-year [1] - Operating cash flow showed a net outflow of 548 million yuan, ranking 10th among peers, a decrease of 318 million yuan from the previous year [1] Key Ratios - The latest debt-to-asset ratio is 58.91%, ranking 7th among peers, an increase of 0.93 percentage points from the previous quarter and 3.92 percentage points from the same period last year [3] - Gross margin stands at 4.52%, ranking 7th among peers, a decrease of 0.21 percentage points from the previous quarter but an increase of 0.44 percentage points year-on-year [3] - Return on equity (ROE) is 0.74%, ranking 6th among peers, a decrease of 0.09 percentage points from the previous year [3] Earnings Per Share and Turnover - Diluted earnings per share are 0.06 yuan, ranking 4th among peers, a decrease of 0.01 yuan year-on-year, reflecting a decline of 14.29% [3] - Total asset turnover ratio is 0.44 times, ranking 5th among peers, a decrease of 0.07 times year-on-year [3] - Inventory turnover ratio is 4.08 times, ranking 3rd among peers, a decrease of 0.81 times from the previous year [3] Shareholder Structure - The number of shareholders is 27,500, with the top ten shareholders holding 603 million shares, accounting for 68.71% of total equity [3] - The largest shareholder is Oriental International (Group) Co., Ltd., holding 48.68% of shares [3]

外资态度来看，本期较上一季未再披露的外资机构即香港中央结算有限公司。 公募基金方面本期较上一季度持股减少的公募基金共计1个，即南方中证全指房地产ETF，持股减少占 比达0.44%。本期较上一季度新披露的公募基金共计51个，主要包括华夏智胜先锋股票(LOF)A、华夏中 证全指房地产ETF、国泰国证房地产行业指数A、华夏中证500指数增强A、中证2000等。本期较上一季 未再披露的公募基金共计3个，包括银河沪深300指数增强A、银河量化优选混合A、银河量化稳进混 合。 2025年4月29日，华联控股(000036.SZ)发布2024年年度报告。截至2025年4月28日，共有56个机构投资 者披露持有华联控股A股股份，合计持股量达4.75亿股，占华联控股总股本的32.02%。其中，前十大机 构投资者包括华联发展集团有限公司、香港中央结算有限公司、杭州里仁股权投资合伙企业(有限合 伙)、柳州瑞恒机电有限责任公司、中国工商银行股份有限公司-南方中证全指房地产交易型开放式指数 证券投资基金、华夏智胜先锋股票(LOF)A、华夏中证全指房地产ETF、国泰国证房地产行业指数A、华 夏中证500指数增强A、中证2000，前十大机 ...

Group 1 - The core viewpoint of the news is that Weiteng Electric (688226.SH) has disclosed its annual report for 2024, highlighting significant institutional investor holdings and changes in share ownership [1] - As of April 25, 2025, a total of 31 institutional investors hold shares in Weiteng Electric, with a combined holding of 66.72 million shares, representing 42.63% of the total share capital [1] - The top ten institutional investors account for 42.50% of the total shares, with a notable decrease of 5.52 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, the Fortune Tianhui Growth Mixed (LOF) A/B, has reduced its holdings by 0.70% compared to the previous quarter [2] - A total of 24 new public funds have been disclosed this period, including notable funds such as Everbright Prudential Quantitative Stock A and Huaxia CSI 500 Index Enhanced A [2] - Eight public funds have not been disclosed this period, including funds like the Collective - CICC New Star A and Fortune Core Advantage Mixed Initiation A [2]

Group 1 - Berry Genomics (000710.SZ) released its 2024 annual report on April 25, 2025, indicating that as of April 24, 2025, 44 institutional investors disclosed holding A-shares, totaling 79.7934 million shares, which accounts for 22.57% of the total share capital [1] - The top ten institutional investors include Chengdu Tianxing Instrument (Group) Co., Ltd., Hongling Siqi (Zhuhai) M&A Equity Investment Enterprise (Limited Partnership), and others, with a combined holding ratio of 22.43%, reflecting a decrease of 1.55 percentage points compared to the previous quarter [1] - In the public fund sector, 37 new public funds were disclosed this period compared to the previous quarter, including funds such as Huatai-PB CSI Precision Medicine Index (LOF) A and Medical Device ETF [1] Group 2 - Foreign institutional investors that did not disclose holdings this period include MORGAN STANLEY & CO. INTERNATIONAL PLC, BARCLAYS BANK PLC, and J.P. Morgan Securities PLC - proprietary funds [2]

Core Insights - Top Group (601689.SH) reported its 2024 annual results, revealing that as of April 23, 2025, 814 institutional investors held a total of 1.344 billion shares, representing 79.73% of the company's total equity [1] - The top ten institutional investors collectively held 68.22% of the shares, with a slight decrease of 1.14 percentage points compared to the previous quarter [1] Institutional Investors - In the public fund sector, 34 funds increased their holdings, with notable funds including Fortune Tianrui Strong Mixed A and Haitong Growth Value Mixed A, accounting for an increase of 0.24% [2] - Conversely, 86 public funds reduced their holdings, with significant reductions from Morgan Dynamic Selected Mixed A and Penghua New Energy Mixed A, representing a decrease of 1.05% [2] - A total of 618 new public funds were disclosed this period, including Dongwu Mobile Internet Mixed A and Huaxia CSI 300 ETF [2] - Additionally, 36 public funds were not disclosed this period, including Yifangda Supply-side Reform Mixed [2] Insurance Capital - In the insurance sector, one insurance company, New China Life Insurance Co., Ltd., reduced its holdings slightly [3] - Two new insurance investors were disclosed, including Taiping Life Insurance Co., Ltd. [3] - One pension fund, Ruizhong Life Insurance Co., Ltd., was not disclosed this period [3]